226 related articles for article (PubMed ID: 37086493)
41. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
[TBL] [Abstract][Full Text] [Related]
42. Identification of Immune-Related Risk Signatures for the Prognostic Prediction in Oral Squamous Cell Carcinoma.
Zou C; Huang D; Wei H; Wu S; Song J; Tang Z; Li X; Ai Y
J Immunol Res; 2021; 2021():6203759. PubMed ID: 34497859
[TBL] [Abstract][Full Text] [Related]
43. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
Lin X; Ding JM; Zheng XZ; Chen JG
Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
[TBL] [Abstract][Full Text] [Related]
44. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
[TBL] [Abstract][Full Text] [Related]
45. Sixteen Cellular Senescence-associated DNA Methylation Signature Predicts Overall Survival in Patients with Head and Neck Squamous Cell Carcinoma.
Ye MH; Huang XY; Li CJ; Wu QJ; Liu F
Chin J Dent Res; 2023 Dec; 26(4):235-248. PubMed ID: 38126369
[TBL] [Abstract][Full Text] [Related]
46. Actin-like protein 8, a member of cancer/testis antigens, supports the aggressive development of oral squamous cell carcinoma cells via activating cell cycle signaling.
Wang L; Xing X; Tian H; Fan Q
Tissue Cell; 2022 Apr; 75():101708. PubMed ID: 35051678
[TBL] [Abstract][Full Text] [Related]
47. TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
Puttipanyalears C; Arayataweegool A; Chalertpet K; Rattanachayoto P; Mahattanasakul P; Tangjaturonsasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
BMC Cancer; 2018 Aug; 18(1):786. PubMed ID: 30081853
[TBL] [Abstract][Full Text] [Related]
48. FOXD2-AS1 Predicts Dismal Prognosis for Oral Squamous Cell Carcinoma and Regulates Cell Proliferation.
Liang X; Chen Z; Wu G
Cell Transplant; 2020; 29():963689720964411. PubMed ID: 33103475
[TBL] [Abstract][Full Text] [Related]
49. LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.
Lee CH; Pan KL; Tang YC; Tsai MH; Cheng AJ; Shen MY; Cheng YM; Huang TT; Lin P
Oncotarget; 2015 Sep; 6(28):25188-201. PubMed ID: 26317789
[TBL] [Abstract][Full Text] [Related]
50. [MicroRNA model that can predict the prognosis of oral squamous cell carcinoma based on bioinformatics analysis].
Zhao G; Li CX; Guo C; Zhu H
Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Dec; 38(6):622-627. PubMed ID: 33377337
[TBL] [Abstract][Full Text] [Related]
51. Porphyromonas gingivalis Activation of Tumor-Associated Macrophages via DOK3 Promotes Recurrence of Oral Squamous Cell Carcinoma.
Li CX; Su Y; Gong ZC; Liu H
Med Sci Monit; 2022 Oct; 28():e937126. PubMed ID: 36210538
[TBL] [Abstract][Full Text] [Related]
52. Genetic Cross-Talk between Oral Squamous Cell Carcinoma and Type 2 Diabetes: The Potential Role of Immunity.
Fan Y; Zhang J; Shi J; Chen L; Long J; Zhang S; Liu S
Dis Markers; 2022; 2022():6389906. PubMed ID: 35634436
[TBL] [Abstract][Full Text] [Related]
53. Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers.
Inchanalkar M; Srivatsa S; Ambatipudi S; Bhosale PG; Patil A; Schäffer AA; Beerenwinkel N; Mahimkar MB
Clin Epigenetics; 2023 May; 15(1):93. PubMed ID: 37245006
[TBL] [Abstract][Full Text] [Related]
54. Prognostic Genomic Markers of Pathological Stage in Oral Squamous Cell Carcinoma.
Kuk SK; Lee JI; Kim K
Head Neck Pathol; 2023 Jun; 17(2):409-421. PubMed ID: 36586077
[TBL] [Abstract][Full Text] [Related]
55. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
Zhang J; Ling T; Wu H; Wang K
J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
[TBL] [Abstract][Full Text] [Related]
56. Identification and validation of transcription factor-driven enhancers of genes related to lipid metabolism in metastatic oral squamous cell carcinomas.
Zhang L; Zhao S; Liu Y; Lv F; Geng X
BMC Oral Health; 2022 Apr; 22(1):126. PubMed ID: 35428233
[TBL] [Abstract][Full Text] [Related]
57. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers.
Gupta R; Strbenac D; Satgunaseelan L; Cheung VK; Narayanappa H; Ashford B; Mitchell J; Thind A; Palme CE; Ch'ng S; Low TH; Wykes J; Willet CE; Chew T; Yang J; Ranson M; Clark JR
Mod Pathol; 2023 Aug; 36(8):100190. PubMed ID: 37080394
[TBL] [Abstract][Full Text] [Related]
58. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.
Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S
Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392
[TBL] [Abstract][Full Text] [Related]
59. The expression and role of tubulin polymerization-promoting protein 3 in oral squamous cell carcinoma.
Xiao T; Lin F; Zhou J; Tang Z
Arch Oral Biol; 2022 Nov; 143():105519. PubMed ID: 36058091
[TBL] [Abstract][Full Text] [Related]
60. A prognostic model for oral squamous cell carcinoma using 7 genes related to tumor mutational burden.
Wu F; Du Y; Hou X; Cheng W
BMC Oral Health; 2022 Apr; 22(1):152. PubMed ID: 35488327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
